Stephen K Doberstein - Net Worth and Insider Trading
Stephen K Doberstein Net Worth
The estimated net worth of Stephen K Doberstein is at least $142,122 dollars as of 2024-04-27. Stephen K Doberstein is the SVP & Chief Scientific Officer of Nektar Therapeutics and owns about 107,668 shares of Nektar Therapeutics (NKTR) stock worth over $142,122. Details can be seen in Stephen K Doberstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen K Doberstein has not made any transactions after 2019-09-05 and currently still holds the listed stock(s).
Transaction Summary of Stephen K Doberstein
Stephen K Doberstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen K Doberstein owns 3 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , Nektar Therapeutics (NKTR) , and Forte Biosciences Inc (FBRX) .
Click here to see the complete history of Stephen K Doberstein’s form 4 insider trades.
Insider Ownership Summary of Stephen K Doberstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-06-15 | director |
| NKTR | Nektar Therapeutics | 2019-09-05 | Chief Scientific Officer |
| FBRX | Forte Biosciences Inc | 2022-05-12 | director |
Stephen K Doberstein Latest Holdings Summary
Stephen K Doberstein currently owns a total of 1 stock. Stephen K Doberstein owns 107,668 shares of Nektar Therapeutics (NKTR) as of September 5, 2019, with a value of $142,122.
Latest Holdings of Stephen K Doberstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-09-05 | 107,668 | 1.32 | 142,122 |
Holding Weightings of Stephen K Doberstein
Stephen K Doberstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen K Doberstein has made a total of 3 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Nektar Therapeutics is the acquisition of 15,000 shares on September 5, 2019, which cost Stephen K Doberstein around $259,200.
Insider Trading History of Stephen K Doberstein
- 1
Stephen K Doberstein Trading Performance
GuruFocus tracks the stock performance after each of Stephen K Doberstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen K Doberstein is 14.34%. GuruFocus also compares Stephen K Doberstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen K Doberstein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen K Doberstein's insider trading performs compared to the benchmark.
Performance of Stephen K Doberstein
Average Return
8.92%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.21 | 14.34 | 16 | 8.92 | -4.42 | -38.71 |
| Relative Return to S&P 500(%) | 10.02 | 9.59 | 14.39 | -6.23 | -27.91 | -48.39 |
Stephen K Doberstein Ownership Network
Ownership Network List of Stephen K Doberstein
Ownership Network Relation of Stephen K Doberstein
Stephen K Doberstein Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Stephen K Doberstein is the director of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
Stephen K Doberstein Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen K Doberstein. You might contact Stephen K Doberstein via mailing address: 129 Elsie Street, San Francisco Ca 94110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
